Maravai LifeSciences Holdings, Inc. Finance Lease, Right-of-Use Asset, before Accumulated Amortization
Maravai LifeSciences Holdings, Inc. (MRVI) had Finance Lease, Right-of-Use Asset, before Accumulated Amortization of $78.60 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization · last filed 2026-02-26
- 2025-12-31: Finance Lease, Right-of-Use Asset, before Accumulated Amortization $78.60M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, before Accumulated Amortization $78.60M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, before Accumulated Amortization $78.60M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, before Accumulated Amortization $0.00.
| Period end | Finance Lease, Right-of-Use Asset, before Accumulated Amortization |
|---|---|
| 2025-12-31 | $78.60M 10-K · filed 2026-02-26 |
| 2024-12-31 | $78.60M 10-K · filed 2026-02-26 |
| 2023-12-31 | $78.60M 10-K · filed 2025-03-18 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 |